HTN Meds Tied to Lower Mortality After Pancreatic Cancer Diagnosis | Health & Fitness
Comments Off on HTN Meds Tied to Lower Mortality After Pancreatic Cancer Diagnosis | Health & Fitness
February 26, 2022
FRIDAY, Feb. 25, 2022 (HealthDay News) — Use of angiotensin II receptor blockers (ARBs) and angiotensin I converting enzyme (ACE) inhibitors after a pancreatic cancer (PC) diagnosis is associated with a reduced mortality risk, according to a study…